All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Combination of Pitavastatin and melatonin shows partial antineoplastic effects in a rat breast carcinoma model

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F14%3A00063189" target="_blank" >RIV/00159816:_____/14:00063189 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.1016/j.acthis.2014.09.010" target="_blank" >http://dx.doi.org/10.1016/j.acthis.2014.09.010</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.acthis.2014.09.010" target="_blank" >10.1016/j.acthis.2014.09.010</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Combination of Pitavastatin and melatonin shows partial antineoplastic effects in a rat breast carcinoma model

  • Original language description

    Our previous results indicated significant tumor-suppressive effects of different statins in rat mammary carcinogenesis. The purpose of this experiment was to examine the chemopreventive effects of Pitavastatin alone and in combination with the pineal hormone melatonin in the model of N-methyl-N-nitrosourea-induced mammary carcinogenesis in female Sprague-Dawley rats. Pitavastatin was administered dietary (10 mg/kg) and melatonin in an aqueous solution (20 mu g/ml). Chemoprevention began 7 days prior tocarcinogen administration and subsequently continued for 15 weeks until autopsy. At autopsy, mammary tumors were removed and prepared for histopathological and immunohistochemical analysis. Compared to controls, Pitavastatin alone reduced average tumorvolume by 58% and lengthened latency by 8 days; on the other hand, the drug increased tumor frequency by 23%. Combined administration of Pitavastatin with melatonin decreased tumor frequency by 23%, tumor volume by 44% and lengthened tumo

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    EB - Genetics and molecular biology

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/ED1.100%2F02%2F0123" target="_blank" >ED1.100/02/0123: St. Anne´s University Hospital Brno - International Clinical Research Center (FNUSA-ICRC)</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2014

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Acta Histochemica

  • ISSN

    0065-1281

  • e-ISSN

  • Volume of the periodical

    116

  • Issue of the periodical within the volume

    8

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    8

  • Pages from-to

    1454-1461

  • UT code for WoS article

    000347362000032

  • EID of the result in the Scopus database